The Independent Voice of
European Private Equity

Advanced Search

Sovereign-backed Bioscript makes bolt-on 

Simon Thompson 19 April 2022

  • The acquisition of Meridian HealthComms will significantly increase Bioscript's geographic footprint.
  • The deal marks Bioscript's third bolt-on since Sovereign backed the business in 2021.

Related Articles

Profile: Fondo Italiano d’Investimento celebrates raise of €1.2bn despite headwinds

08/05/24

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24